From Plenary Session:
“We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to discuss diffuse large B-cell lymphoma (DLBCL). We talk about bad cancer drugs and bad Twitter users.”
Papa on Plenary Session (5/21) - DLBCL, Bad Cancer Drugs and Bad Twitter Users
From Plenary Session:
Listen NOW!
Keep reading with a 7-day free trial
Subscribe to Papa Heme's Educational Portal to keep reading this post and get 7 days of free access to the full post archives.